Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio Composition

     Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio
                                 Composition

PR Newswire

PHILADELPHIA, Oct. 1, 2013

PHILADELPHIA, Oct. 1, 2013 /PRNewswire/ --Aberdeen Israel Fund, Inc. (the
"Fund") (NYSE MKT: ISL), a closed-end equity fund, announced today its
performance data and portfolio composition as of August 31, 2013.

(Logo: http://photos.prnewswire.com/prnh/20121106/NE07292LOGO )

The Fund's total returns for various periods through August 31, 2013 are
provided below. (All figures are based on distributions reinvested at the
dividend reinvestment price and are stated net-of-fees):

           Cumulative as of        Annualized as of 08/31/13
           08/31/13
           1 Month  3 Month  YTD   1 Year 3 Years 5 Years 10      Since
                                                          Years   Inception
NAV        -3.2     0.7      9.9   28.0   6.3     6.1     10.0    7.1
Market     -2.9     -1.8     11.6  27.4   4.4     5.1     10.5    6.3
Price
TA-100     -2.6     -0.3     6.4   20.1   2.9     2.9     12.3    7.1

On August 31, 2013, the Fund's net assets amounted to US$71.7 million and the
Fund's NAV per share was $17.03.

As of August 31, 2013, the portfolio was invested as follows:

                       Percent of
Portfolio Composition
                       Net Assets
Financials             22.8
Information Technology 18.6
Health Care            17.9
Consumer Staples       15.0
Materials              14.2
Telecommunications     4.8
Industrials            3.4
Consumer Discretionary 2.1
Cash                   1.3

The Fund's ten largest equity holdings as of August 31, 2013, representing
66.2% of net assets, were:

                                  Percent of
Stock
                                  Net Assets
Check Point Software Technologies 11.1
Teva Pharmaceutical Industries    9.1
Perrigo                           8.9
OSEM Investment                   6.5
Frutarom Industries               5.9
Israel Chemicals                  5.8
United Mizrahi Bank               5.1
Bezeq Israeli Telecommunication   4.8
Rami Levi                         4.6
Azrieli Group                     4.6

Important Information
Aberdeen Asset Management Inc. has prepared this report based on information
sources believed to be accurate and reliable. However, the figures are
unaudited and neither the Fund, Aberdeen Asset Managers Limited (effective
March 1, 2012, the Investment Adviser), nor any other person guarantees their
accuracy. Investors should seek their own professional advice and should
consider the investment objectives, risks, charges and expenses before acting
on this information. Aberdeen is a U.S. registered service mark of Aberdeen
Asset Management PLC.

Closed-end funds are traded on the secondary market through one of the stock
exchanges. The Fund's investment return and principal value will fluctuate so
that an investor's shares may be worth more or less than the original cost.
Shares of closed-end funds may trade above (a premium) or below (a discount)
the net asset value (NAV) of the fund's portfolio. There is no assurance that
the Fund will achieve its investment objective.

Total return figures with distributions reinvested at the dividend
reinvestment price are stated net-of-fees and represents past performance.
Past performance is not indicative of future results, current performance may
be higher or lower. Holdings are subject to change and are provided for
informational purposes only and should not be deemed as a recommendation to
buy or sell the securities shown. Inception date October 29, 1992.

If you wish to receive this information electronically, please contact:
InvestorRelations@aberdeen-asset.com



SOURCE Aberdeen Israel Fund, Inc.

Website: http://www.aberdeenisl.com
Contact: Aberdeen Asset Management Inc., Investor Relations, 866-839-5205,
InvestorRelations@aberdeen-asset.com
 
Press spacebar to pause and continue. Press esc to stop.